semaglutide hashimoto's Can someone with take the new class of Semaglutide, Mounjaro, WeGovy, or Ozempic? Hashimoto's and GLP-1: what thyroid

No diabetic retinopathy at baseline: typically annual exams, with earlier follow-up if high baseline A1c, large early A1c drop, or new symptoms Mild nonproliferative diabetic retinopathy: every six to twelve months, shorter intervals if rapid glucose changes or symptoms appear Moderate nonproliferative retinopathy: every three to six months Severe nonproliferative retinopathy: every two to three months Proliferative diabetic retinopathy or prior macular edema: individualized schedule, often every two to four months when stable, more frequent when starting treatment Starting semaglutide may justify scheduling one additional exam during the first six months in higher-risk patients to catch any early worsening

BPC-157 interacts with the nitric oxide system in a surprisingly sophisticated way

2018 Jun 7;13(6):e0198626.

Buffered NAD+ ships with a pH stabilizer (most commonly Tris) that brings the reconstituted solution closer to physiological pH (~7-8.5), while unbuffered NAD+ reconstitutes acidic (~pH 3-4) and is more often associated with injection-site stinging

Both oral and injectable semaglutide belong to the GLP-1 receptor agonist class of medications and have shown promising outcomes, but they differ in their effectiveness and side effect profiles

Wegovy (pill): Taken once daily, starting with 1.5 mg and gradually increased every 30 days, or as needed but not earlier than every 30 days, up to 25 mg